Electronic eRAPID3 (Routine Assessment of Patient Index Data): Opportunities and complexities

Clinical and Experimental Rheumatology

Volumn 34, Issue , 2016, Pages 49-53

  Pincus, Theodore ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Electronic medical record (EMR); Information technology; Multidimensional health assessment questionnaire (MDHAQ); Rheumatoid arthritis; Routine assessment of patient index data (RAPID3)

Indexed keywords

ARTICLE; ELECTRONIC MEDICAL RECORD; FIBROMYALGIA; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INFLAMMATION; MEDICAL EDUCATION; PRIORITY JOURNAL; ROUTINE ASSESSMENT OF PATIENT INDEX DATA; SCORING SYSTEM; SOFTWARE; VISUAL ANALOG SCALE; ARTHRITIS, RHEUMATOID; CHECKLIST; DISABILITY; ELECTRONIC HEALTH RECORD; HEALTH STATUS; HEALTH STATUS INDICATOR; MEDICAL INFORMATICS; MOBILE APPLICATION; MOBILE PHONE; PATHOPHYSIOLOGY; PATIENT-REPORTED OUTCOME; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; PSYCHOLOGY; QUESTIONNAIRE; REPRODUCIBILITY; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX; TELEMEDICINE;

ARTHRITIS, RHEUMATOID; CELL PHONES; CHECKLIST; DISABILITY EVALUATION; ELECTRONIC HEALTH RECORDS; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; MEDICAL INFORMATICS; MOBILE APPLICATIONS; PATIENT REPORTED OUTCOME MEASURES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TELEMEDICINE;

EID: 85018296294     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. PINCUS T, BERGMAN MJ, YAZICI Y: RAPID3-an index of physical function, pain, and global status as "vital signs" to improve care for people with chronic rheumatic diseases. Bull NYU Hosp Jt Dis 2009; 67: 211-25.
2. PINCUS T, SWEARINGEN CJ, BERGMAN M, YAZICI Y: RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol 2008; 35: 2136-47.
3. PINCUS T: Pain, function, and RAPID scores: vital signs in chronic diseases, analogous to pulse and temperature in acute diseases and blood pressure and cholesterol in long-term health. Bull NYU Hosp Jt Dis 2008; 66: 155-65.
4. PINCUS T, SOKKA T, KAUTIAINEN H: Further development of a physical function scale on a MDHAQ [corrected] for standard care of patients with rheumatic diseases. J Rheumatol 2005; 32: 1432-9.
5. PINCUS T, SWEARINGEN C, WOLFE F: Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 1999; 42: 2220-30.
6. PINCUS T, CASTREJON I: MDHAQ/RAPID3 Scores: Quantitative Patient History Data in a Standardized "Scientific" Format for Optimal Assessment of Patient Status and Quality of Care in Rheumatic Diseases. Bull NYU Hosp Jt Dis 2011; 69: 201-14.
7. PINCUS T, MACLEAN R, YAZICI Y, HARRINGTON JT: Quantitative measurement of patient status in the regular care of patients with rheumatic diseases over 25 years as a continuous quality improvement activity, rather than traditional research. Clin Exp Rheumatol 2007; 25 (6 Suppl. 47): 69-81.
8. PINCUS T: Electronic multidimensional health assessment questionnaire (eMDHAQ): past, present and future of a proposed single data management system for clinical care, research, quality improvement, and monitoring of long-term outcomes. Clin Exp Rheumatol 2016; 34 (Suppl. 101): S17-33.
9. BOERS M, TUGWELL P: The validity of pooled outcome measures (indices) in rheumatoid arthritis clinical trials. J Rheumatol 1993; 20: 568-74.
10. van der HEIJDE DM, van't HOF M, van RIEL PL, van de PUTTE LB: Validity of single variables and indices to measure disease activity in rheumatoid arthritis. J Rheumatol 1993; 20: 538-41.
11. PREVOO ML, van't HOF MA, KUPER HH, van LEEUWEN MA, van de PUTTE LB, van RIEL PL: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
12. PINCUS T, SWEARINGEN CJ, BERGMAN MJ et al.: RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds. Arthritis Care Res (Hoboken) 2010; 62: 181-9.
13. PINCUS T, YAZICI Y, BERGMAN MJ: RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care. Rheum Dis Clin North Am 2009; 35: 773-8, viii.
14. PINCUS T, ASKANASE AD, SWEARINGEN CJ: A multi-dimensional health assessment questionnaire (MDHAQ) and routine assessment of patient index data (RAPID3) scores are informative in patients with all rheumatic diseases. Rheum Dis Clin North Am 2009; 35: 819-27, x.
15. PINCUS T: Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care? Bull NYU Hosp Jt Dis 2009; 67: 254-66.
16. PINCUS T: Is a self-report RAPID3 score a reasonable alternative to a DAS28 in usual clinical care? J Clin Rheumatol 2009; 15: 215-7.
17. PINCUS T, FURER V, KEYSTONE E, YAZICI Y, BERGMAN MJ, LUIJTENS K: RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol. Arthritis Care Res (Hoboken) 2011; 63: 1142-9.
18. PINCUS T, YAZICI Y, CASTREJON I: Pragmatic and Scientific Advantages of MDHAQ/RAPID3 Completion by All Patients at All Visits in Routine Clinical Care. Bull NYU Hosp Jt Dis 2012; 70 (Suppl. 1): 30-6.
19. CASTREJON I, BERGMAN MJ, PINCUS T: MDHAQ/RAPID3 to recognize improvement over 2 months in usual care of patients with osteoarthritis, systemic lupus erythematosus, spondyloarthropathy, and gout, as well as rheumatoid arthritis. J Clin Rheumatol 2013; 19: 169-74.
20. PINCUS T: RAPID3, an index of only 3 patient self-report core data set measures, but not ESR, recognizes incomplete responses to methotrexate in usual care of patients with rheumatoid arthritis. Bull Hosp Jt Dis (2013) 2013 ;71: 117-20.
21. CASTREJON I, PINCUS T, WENDLING D, DOUGADOS M: Responsiveness of a simple RAPID-3-like index compared to diseasespecific BASDAI and ASDAS indices in patients with axial spondyloarthritis. RMD Open 2016; 2: e000235.
22. ALETAHA D, SMOLEN J: The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005; 23 (Suppl. 39): S100-8.
23. FRIES JF, SPITZ P, KRAINES RG, HOLMAN HR: Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-45.
24. PINCUS T, YAZICI Y, BERGMAN M: A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers. Best Pract Res Clin Rheumatol 2007; 21: 755-87.
25. PINCUS T, OLIVER AM, BERGMAN MJ: How to collect an MDHAQ to provide rheumatology vital signs (function, pain, global status, and RAPID3 scores) in the infrastructure of rheumatology care, including some misconceptions regarding the MDHAQ. Rheum Dis Clin North Am 2009; 35: 799-812, x.
26. GOLDSMITH CH, SMYTHE HA, HELEWA A: Interpretation and power of a pooled index. J Rheumatol 1993; 20: 575-8.
27. PINCUS T, SOKKA T: Complexities in the quantitative assessment of patients with rheumatic diseases in clinical trials and clinical care. Clin Exp Rheumatol 2005; 23 (Suppl. 39): S1-9.
28. PINCUS T, YAZICI Y, SOKKA T: Complexities in assessment of rheumatoid arthritis: absence of a single gold standard measure. Rheum Dis Clin North Am 2009; 35: 687-97, v.
29. CASTREJON I, MCCOLLUM L, TANRIOVER MD, PINCUS T: Importance of patient history and physical examination in rheumatoid arthritis compared to other chronic diseases: Results of a physician survey. Arthritis Care Res (Hoboken) 2012; 64: 1250-5.
30. WEED LL: Medical records that guide and teach. N Engl J Med 1968; 278: 652-7 concl.
31. PINCUS T: Are patient questionnaire scores as "scientific" as laboratory tests for rheumatology clinical care? Bull NYU Hosp Jt Dis 2010; 68: 130-9.
32. PINCUS T, CASTREJON I: Are patient selfreport questionnaires as "scientific" as biomarkers in "treat-to-target" and prognosis in rheumatoid arthritis? Curr Pharm Des 2015; 21: 241-56.
33. DECKER JL: American Rheumatism Association nomenclature and classification of arthritis and rheumatism (1983). Arthritis Rheum 1983; 26: 1029-32.
34. FUCHS HA, BROOKS RH, CALLAHAN LF, PINCUS T: A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis. Arthritis Rheum 1989; 32: 531-7.
35. FUCHS HA, PINCUS T: Reduced joint counts in controlled clinical trials in rheumatoid arthritis. Arthritis Rheum 1994; 37: 470-5.
36. PINCUS T, SCHUR PH, ROSE JA, DECKER JL, TALAL N: Measurement of serum DNAbinding activity in systemic lupus erythematosus. N Engl J Med 1969; 281: 701-5.
37. NICASSIO PM, WALLSTON KA, CALLAHAN LF, HERBERT M, PINCUS T: The measurement of helplessness in rheumatoid arthritis. The development of the arthritis helplessness index. J Rheumatol 1985; 12: 462-7.
38. CALLAHAN LF, BROOKS RH, SUMMEY JA, PINCUS T: Quantitative pain assessment for routine care of rheumatoid arthritis patients, using a pain scale based on activities of daily living and a visual analog pain scale. Arthritis Rheum 1987; 30: 630-6.
39. FRASER AD, van KUIJK AW, WESTHOVENS R et al.: A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis. Ann Rheum Dis 2005; 64: 859-64.
40. COATES LC, FitzGERALD O, GLADMAN DD et al.: Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease. Arthritis Rheum 2013; 65: 1504-9.
41. PINCUS T, SEGURADO OG: Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count. Ann Rheum Dis 2006; 65: 820-2.
42. ANDERSON J, CAPLAN L, YAZDANY J et al.: Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) 2012; 64: 640-7.
43. SOKKA T, PINCUS T: Joint counts to assess rheumatoid arthritis for clinical research and usual clinical care: advantages and limitations. Rheum Dis Clin North Am 2009; 35: 713-22, v-vi.
44. PINCUS T: Advantages and limitations of quantitative measures to assess rheumatoid arthritis: joint counts, radiographs, laboratory tests, and patient. Bull NYU Hosp Jt Dis 2006; 64: 32-9.
45. UHLIG T, KVIEN TK, PINCUS T: Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis. Ann Rheum Dis 2009; 68: 972-5.
46. TURCHETTI G, SMOLEN JS, KAVANAUGH A, BRAUN J, PINCUS T, BOMBARDIERI S: Treat-to-target in rheumatoid arthritis: clinical and pharmacoeconomic considerations. Introduction. Clin Exp Rheumatol 2012; 30 (Suppl. 73): S1.
47. SMOLEN JS, ALETAHA D, BIJLSMA JW et al.: Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010; 69: 631-7.
48. PINCUS T, CHUNG C, SEGURADO OG, AMARA I, KOCH GG: An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis. J Rheumatol 2006; 33: 2146-52.
49. PINCUS T, AMARA I, SEGURADO OG, BERGMAN M, KOCH GG: Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials. J Rheumatol 2008; 35: 201-5.
50. PINCUS T, BERGMAN MJ, YAZICI Y, HINES P, RAGHUPATHI K, MacLEAN R: An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures. Rheumatology (Oxford) 2008; 47: 345-9.
51. PINCUS T, HINES P, BERGMAN MJ, YAZICI Y, ROSENBLATT LC, MacLEAN R: Proposed severity and response criteria for Routine Assessment of Patient Index Data (RAPID3): results for categories of disease activity and response criteria in abatacept clinical trials. J Rheumatol 2011; 38: 2565-71.
52. PINCUS T, ZELINGER D, BOLCE RJ: High/moderate versus low activity/remission patient proportions are similar according to DAS28 (disease activity score), CDAI (clinical disease actviity index) and RAPID3 (routine assessment of patient index data) in ATTRACT and ASPIRE Infliximab (INFX) clinical trials in patients with rheumatoid arthritis (RA) [abstract]. Ann Rheum Dis 2009; 68 (Suppl. 3): 433.
53. PINCUS T, RICHARDSON B, STRAND V, BERGMAN MJ: Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents. Clin Exp Rheumatol 2014; 32 (Suppl. 85): S47-54.
54. BERGMAN MJ, REISS W, CHUNG C, WONG P, TURPCU A: Composite Indices Using 3 or 4 Components of the Core Data Set Have Similar Predictive Ability to Measure Disease Activity in RA: Evidence from the DANCER and REFLEX Studies. Autoimmune Dis 2013; 2013: 367190.
55. TYMMS K, ZOCHLING J, SCOTT J et al.: Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity. Arthritis Care Res (Hoboken) 2014; 66: 190-6.
56. CALLAHAN LF, PINCUS T: A clue from a selfreport questionnaire to distinguish rheumatoid arthritis from noninflammatory diffuse musculoskeletal pain. The P-VAS:D-ADL ratio. Arthritis Rheum 1990; 33: 1317-22.
57. DeWALT DA, REED GW, PINCUS T: Further clues to recognition of patients with fibromyalgia from a simple 2-page patient multidimensional health assessment questionnaire (MDHAQ). Clin Exp Rheumatol 2004; 22: 453-61.
58. PINCUS T, HASSETT AL, CALLAHAN LF: Clues on the MDHAQ to identify patients with fibromyalgia and similar chronic pain conditions. Rheum Dis Clin North Am 2009; 35: 865-9, xii.
59. WACHTER RM: The Digital Doctor: Hope, Hype, And Harm At The Dawn Of Medicine's Computer Age. New York: McGraw-Hill Education; 2015, 330 pages.
60. SOKKA T, ABELSON B, PINCUS T: Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008; 26 (Suppl. 51): S35-61.
61. BERGMAN MJ, CASTREJON I, PINCUS T: RHEUMDOC: a one-page RHEUMatology DOCtor form with four physician global estimates for overall status, inflammation, damage, and symptoms based on neither inflammation nor damage. Bull Hosp Jt Dis (2013). 2014; 72: 142-7.
62. CASTREJON I, GIBSON KA, BLOCK JA, EVERAKES SL, JAIN R, PINCUS T: RheuMetric a physician checklist to record patient levels of inflammation, damage and distress as quantitative data rather than as narrative impressions. Bull Hosp Jt Dis (2013). 2015; 73: 178-84.